Ailing Zhong
Impact in
-
- MicroRNA in disease regulation
- Cancer Genomics and Diagnostics
-
- Pancreatic and Hepatic Oncology Research
- Inflammatory Biomarkers in Disease Prognosis
- PARP inhibition in cancer therapy
Papers in
-
- DNA Repair Mechanisms 5
- CRISPR and Genetic Engineering 4
- RNA modifications and cancer 3
- Oncology 10
- Pancreatic and Hepatic Oncology Research 4
- Cancer-related Molecular Pathways 2
- PARP inhibition in cancer therapy 2
- Co-authors
- Lin Guo (13 shared papers)Renquan Lu (11 shared papers)Yanchun Wang (8 shared papers)Suhong Xie (7 shared papers)Hongqin Zhang (7 shared papers)Hui Zheng (6 shared papers)Chien‐shan Cheng (4 shared papers)Yiwen Yu (3 shared papers)
- Journals
- Frontiers in Oncology (3 papers)Biochemical and Biophysical Research Communications (2 papers)Signal Transduction and Targeted Therapy (1 paper)Medicine (1 paper)BioMed Research International (1 paper)
- Partner nations
- ChinaUnited StatesJapan
In The Last Decade
Ailing Zhong
28 papers receiving 360 citations
Peers
Comparison fields: 5 of 65
- Cancer Research 76
- Oncology 107
- Molecular Biology 166
- Reproductive Medicine 14
- Complementary and alternative medicine 13
Countries citing papers authored by Ailing Zhong
This map shows the geographic impact of Ailing Zhong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ailing Zhong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ailing Zhong more than expected).
Fields of papers citing papers by Ailing Zhong
This network shows the impact of papers produced by Ailing Zhong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ailing Zhong. The network helps show where Ailing Zhong may publish in the future.
Co-authors
The 25 scholars most cited alongside Ailing Zhong, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 28 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 43 | |
| 2 | 2020 | 40 | |
| 3 | 2020 | 32 | |
| 4 | 2019 | 30 | |
| 5 | 2022 | 22 | |
| 6 | 2019 | 22 | |
| 7 | 2021 | 20 | |
| 8 | 2020 | 20 | |
| 9 | 2018 | 19 | |
| 10 | 2017 | 18 | |
| 11 | 2018 | 14 | |
| 12 | 2019 | 14 | |
| 13 | 2019 | 14 | |
| 14 | 2016 | 10 | |
| 15 | 2019 | 9 | |
| 16 | 2019 | 9 | |
| 17 | 2015 | 7 | |
| 18 | 2022 | 5 | |
| 19 | 2023 | 3 | |
| 20 | [Effect of metformin on proliferation and apoptosis of rat prolactinoma MMQ cells and related mechanisms]. | 2017 | 3 |
About Ailing Zhong
Ailing Zhong is a scholar working on Molecular Biology, Oncology, Surgery, Cancer Research and Epidemiology, having authored 28 papers that have together received 367 indexed citations. Recurring topics across this work include DNA Repair Mechanisms (5 papers), Pancreatic and Hepatic Oncology Research (4 papers), CRISPR and Genetic Engineering (4 papers), RNA modifications and cancer (3 papers), Cancer-related Molecular Pathways (2 papers), PARP inhibition in cancer therapy (2 papers), Growth Hormone and Insulin-like Growth Factors (2 papers) and Pituitary Gland Disorders and Treatments (2 papers). The work is most often cited by research in Cancer Research (76 citations), Oncology (107 citations), Molecular Biology (166 citations), Reproductive Medicine (14 citations) and Complementary and alternative medicine (13 citations). Ailing Zhong has collaborated with scholars based in China, United States and Japan. Frequent co-authors include Lin Guo, Renquan Lu, Yanchun Wang, Suhong Xie, Hongqin Zhang, Hui Zheng, Chien‐shan Cheng, Yiwen Yu, Miaomiao Chen and Ying Tong. Their work appears in journals such as Frontiers in Oncology, Biochemical and Biophysical Research Communications, Signal Transduction and Targeted Therapy, Medicine and BioMed Research International.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.